Chung, S., Holst, J., Teng, C., Cooper, A., Wei, J., Koh, E.-S., … Hovey, E. (2025). TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma. In Neuro-Oncology (Vol. 27, pp. v425–v425). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaf201.1679

Chung, Sylvia, Jeff Holst, Christina Teng, Adam Cooper, Joe Wei, Eng-Siew Koh, Nicholas Yeo, et al. “TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma.” In Neuro-Oncology, 27:v425–v425. Oxford University Press (OUP), 2025. https://doi.org/10.1093/neuonc/noaf201.1679.

Chung S, Holst J, Teng C, Cooper A, Wei J, Koh E-S, et al. TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma. In: Neuro-Oncology. Oxford University Press (OUP); 2025. p. v425–v425.

Chung, Sylvia, et al. “TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma.” Neuro-Oncology, vol. 27, no. Supplement_5, Oxford University Press (OUP), 2025, pp. v425–v425. Crossref, doi:10.1093/neuonc/noaf201.1679.

Chung S, Holst J, Teng C, Cooper A, Wei J, Koh E-S, Yeo N, Sim H-W, Killen AJ, Gayaman R, Lynch S, Mandala A, Murray C, Joshi S, McDonald K, Ashley D, Desjardins A, Sampson J, Archer G, Lemech C, Hovey E. TIP-19. INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma. Neuro-Oncology. Oxford University Press (OUP); 2025. p. v425–v425.